Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7952 results

Sort By:

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Study ID: NCT05484973
Start Date: 2024-11-08
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

99

Intervention / Treatment

AMMA Portalbe Scalp Cooling System

Sponsor

Cooler Heads Care Inc.

Source: clinicaltrials.gov

Share:
Add to list

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

Study ID: NCT04459273
Start Date: 2020-08-27
End Date: 2026-07-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

Computed Tomography

Gallium Ga 68 FAPi-46

Positron Emission Tomography

18F-FDG

Sponsor

Jonsson Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Study ID: NCT04175431
Start Date: 2020-09-30
End Date: 2031-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Positron Emission Tomography

Lymphadenectomy

Radiation Therapy

Abiraterone Acetate

Prednisone

Computed Tomography

Abiraterone

PSMA PET Scan

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Study ID: NCT02861573
Start Date: 2016-11-17
End Date: 2027-10-22
Study Type

Interventional

Study Phase

Phase2

No. of Participants

1200

Intervention / Treatment

Pembrolizumab 200 mg

Olaparib 400 mg

Docetaxel 75 mg/m^2

Prednisone 5 mg

Enzalutamide 160 mg

Dexamethasone 8 mg

Olaparib 300 mg

Abiraterone acetate 1000 mg

Lenvew

Pembrolizumab/Vibostolimab coformulation

Carboplatin

Etoposide

Belzutifan 120mg

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Feasibility of Acquiring Hyperpolarized Imaging in Patients With Primary CNS Lymphoma

Study ID: NCT04656431
Start Date: 2021-06-29
End Date: 2025-03-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

25

Intervention / Treatment

Hyperpolarized pyruvate (13C)

Magnetic resonance imaging (MRI)

Sponsor

James Rubenstein

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

Study ID: NCT06263231
Start Date: 2024-06-28
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

333

Intervention / Treatment

INT230-6

Eribulin

Trabectedin

On the feopanib

Sponsor

Intensity Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Study ID: NCT03486873
Start Date: 2018-08-21
End Date: 2043-08-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

3500

Intervention / Treatment

Pembrolizumab

Standard of Care (SOC)

Lenvew

Flapberry

MK-4280

MK-4280A

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

Study ID: NCT05092373
Start Date: 2022-04-29
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

43

Intervention / Treatment

Atezolizumab

Cabozantinib S-malate

Nab-paclitaxel

Tumor Treating Fields Therapy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines

Study ID: NCT04595422
Start Date: 2020-07-02
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

Educational Intervention

Educational Intervention

Administration questionnaire

Survey Administration

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

Study ID: NCT05541822
Start Date: 2023-01-17
End Date: 2025-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Abn401

Sponsor

ABION INC

Source: clinicaltrials.gov

Share:
Add to list